- Home
- CATX vs VHI Comparison
CATX vs VHI Comparison
Compare CATX & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- VHI
- Stock Information
- Founded
- CATX 1983
- VHI 1932
- Country
- CATX United States
- VHI United States
- Employees
- CATX N/A
- VHI N/A
- Industry
- CATX Medical/Dental Instruments
- VHI Major Chemicals
- Sector
- CATX Health Care
- VHI Industrials
- Exchange
- CATX Nasdaq
- VHI Nasdaq
- Market Cap
- CATX 239.0M
- VHI 447.6M
- IPO Year
- CATX N/A
- VHI N/A
- Fundamental
- Price
- CATX $3.97
- VHI $18.07
- Analyst Decision
- CATX Strong Buy
- VHI Sell
- Analyst Count
- CATX 11
- VHI 1
- Target Price
- CATX $12.90
- VHI $12.00
- AVG Volume (30 Days)
- CATX 1.3M
- VHI 25.2K
- Earning Date
- CATX 08-11-2025
- VHI 08-07-2025
- Dividend Yield
- CATX N/A
- VHI 1.78%
- EPS Growth
- CATX N/A
- VHI 4465.30
- EPS
- CATX N/A
- VHI 4.11
- Revenue
- CATX $1,471,000.00
- VHI $2,112,800,000.00
- Revenue This Year
- CATX N/A
- VHI $22.20
- Revenue Next Year
- CATX N/A
- VHI $7.66
- P/E Ratio
- CATX N/A
- VHI $4.50
- Revenue Growth
- CATX N/A
- VHI 7.82
- 52 Week Low
- CATX $1.60
- VHI $14.10
- 52 Week High
- CATX $16.55
- VHI $41.75
- Technical
- Relative Strength Index (RSI)
- CATX 61.19
- VHI 60.53
- Support Level
- CATX $3.33
- VHI $18.15
- Resistance Level
- CATX $3.69
- VHI $19.23
- Average True Range (ATR)
- CATX 0.38
- VHI 0.91
- MACD
- CATX 0.01
- VHI 0.20
- Stochastic Oscillator
- CATX 64.23
- VHI 56.82
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.